CLOs on the Move

Pieris

www.pieris.com

 
Pieris Pharmaceuticals is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Pieris is listed on the NASDAQ and trades under the ticker symbol PIRS.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.pieris.com
  • 255 State Street 9th floor
    Boston, MA USA 02109
  • Phone: 857.246.8998

Executives

Name Title Contact Details
Ahmed Mousa
 Senior Vice President, Corporate Operations and General Counsel Profile
Ahmed Mousa
 Senior Vice President, Chief Business Officer and General Counsel Profile

Similar Companies

Haemacure Corporation

Haemacure Corporation is a MontríŠal, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Covis Pharma

Covis Pharma is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses. Our paramount concern is patient`s outcomes as we focus on improving the health of people with serious medical conditions. Covis Pharma is a standalone company with global commercial, business development, product supply chain, product development, quality and regulatory functions based in Zug, Switzerland.

Greenwich Hospital

A member of Yale New Haven Health System, Greenwich Hospital is a teaching institution.

StarVista

We deliver high impact services through counseling, skill development, and crisis prevention to children, youth, adults and families.

X-37

X-37 is a pharmaceutical discovery and development company